Adrian Haigh Sells 22,223 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,223 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $9.32, for a total transaction of $207,118.36. The transaction was disclosed in a legal filing with the SEC, which […]

Related Keywords

United States ,Craig Hallum ,Gendell Jeffrey ,Adrian Haigh ,Eudaimonia Advisors ,Fennec Pharmaceuticals ,Hartford Financial Management Inc ,Capital Management ,Worth Venture Partners ,News Ratings For Fennec Pharmaceuticals Daily ,Fennec Pharmaceuticals Stock Performance ,Institutional Investors Weigh In On Fennec Pharmaceuticals ,Fennec Pharmaceuticals Inc ,Quarter For Fennec Pharmaceuticals ,Get Free Report ,Pharmaceuticals Inc ,Venture Partners ,Financial Management ,Sodium Thiosulfate ,Fennec Pharmaceuticals Daily ,Nasdaq Fenc ,Pufenc ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,